<DOC>
	<DOCNO>NCT02096159</DOCNO>
	<brief_summary>The primary purpose study determine routine use prophylactic ( preventive ) antibiotic repair mid-to-distal hypospadias beneficial .</brief_summary>
	<brief_title>Prophylactic Antibiotics Placebo After Hypospadias Repair</brief_title>
	<detailed_description>Participants multicenter , double-blind study randomize receive trimethoprim-sulfamethoxazole placebo 10 day postoperatively . Short- intermediate-term result publish participant complete 6 month 5 year follow-up , respectively .</detailed_description>
	<mesh_term>Hypospadias</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<criteria>midtodistal shaft hypospadias singlestage hypospadias repair length urethral repair ( urethroplasty ) less equal 20 mm placement opendrainage urethral stent time hypospadias repair , intend duration stenting 510 day postoperatively previous hypospadias repair prior adverse/allergic reaction contraindication trimethoprimsulfamethoxazole crossreactivity exist medication trimethoprimsulfamethoxazole patient condition elevate risk infection adverse outcome potential infection ( e.g. , HIV/AIDS , poorly control diabetes mellitus immunocompromising condition , congenital heart disease ) use antibiotic within seven day prior hypospadias repair foreskin reconstruction time hypospadias repair prescription oral antibiotic Study Medication time hypospadias repair</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Hypospadias</keyword>
	<keyword>Anti-Bacterial Agents</keyword>
</DOC>